Indian Accounting Research Analyst, Trudence Capital Advisors

Nitin Mangal

Indian Accounting Research Analyst

Trudence Capital Advisors

Trudence Capital Advisors Private Limited is a SEBI-registered Research Analyst, holding SEBI registration number INH000015747. Our firm is dedicated to providing independent and unbiased research on Indian mid to large-cap companies. Trudence Capital is known for its counter-consensus views, with a focus on forensic research and on-ground primary investigations. Our research approach is thorough, involving detailed analysis of accounting practices and governance, alongside extensive channel checks.

Independent & Unbiased Research

Equity Capital Markets

Lava International / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/lava-international" target="_blank" data-smartkarma-citation="entities:34998:1" rel="noopener">Lava International (9263793Z IN) </a> is one of the leading end-to-end focused mobile handset and mobile handset Solutions Company based in India, with operations in a number of countries.</li>
<li>Major business risk arises from external environment, as Lava is one of the prominent leaders in feature phone segment, where the market is dying. </li>
<li>Key forensic takeaways pertain to ECL provisioning and some absurd trend in line items. There are several discomforts on the governance end as well which must not be ignored.</li>
</ul>



Lava International (9263793Z IN)  is one of the leading end-to-end focused mobile handset and mobile handset Solutions Company based in India, with operations in a number of countries.
Major business risk arises from external environment, as Lava is one of the prominent leaders in feature phone segment, where the market is dying. 
Key forensic takeaways pertain to ECL provisioning and some absurd trend in line items. There are several discomforts on the governance end as well which must not be ignored.


Lava International IPO: Forensic Analysis

APAC IPOs & Placements, Aequitas Research

Clarence Chu

APAC IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Sahajanand Medical Technologies Ltd / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/sahajanand-medical-technologies-ltd" target="_blank" data-smartkarma-citation="entities:35324:1" rel="noopener">Sahajanand Medical Technologies Ltd (544309Z IN)</a> is looking to raise US$202m in its upcoming India IPO. The deal will be run by Axis Capital, Bank of America, Edelweiss and UBS.</li>
<li>Sahajanand Medical Technologies is a medical devices company that researches, designs, develops, manufactures and markets vascular devices.</li>
<li>The product portfolio is led by its flagship coronary stent, Supraflex Cruz, where the product had been implanted in over 400,000 patients globally as of Mar 2021.</li>
</ul>



Sahajanand Medical Technologies Ltd (544309Z IN) is looking to raise US$202m in its upcoming India IPO. The deal will be run by Axis Capital, Bank of America, Edelweiss and UBS.
Sahajanand Medical Technologies is a medical devices company that researches, designs, develops, manufactures and markets vascular devices.
The product portfolio is led by its flagship coronary stent, Supraflex Cruz, where the product had been implanted in over 400,000 patients globally as of Mar 2021.


Sahajanand Medical Technologies Pre-IPO Tearsheet

<ul>
<li>
<a href="https://www.smartkarma.com/entities/lava-international" target="_blank" data-smartkarma-citation="entities:34998:1" rel="noopener">Lava International (9263793Z IN)</a> is looking to raise around US$188m in its upcoming India IPO. The deal will be run by Axis Capital, BOB Capital, DAM Capital, and SBI Capital.</li>
<li>Lava International is a mobile device manufacturer in India that covers the entire end-to-end process, from designing and manufacturing to distribution and servicing mobile handsets, tablets and other electronics accessories.</li>
<li>According to F&amp;S, the firm had a market share of 10.2% in the less than US$70 equivalent range market in India, in terms of sales volume in FY21.</li>
</ul>



Lava International (9263793Z IN) is looking to raise around US$188m in its upcoming India IPO. The deal will be run by Axis Capital, BOB Capital, DAM Capital, and SBI Capital.
Lava International is a mobile device manufacturer in India that covers the entire end-to-end process, from designing and manufacturing to distribution and servicing mobile handsets, tablets and other electronics accessories.
According to F&amp;S, the firm had a market share of 10.2% in the less than US$70 equivalent range market in India, in terms of sales volume in FY21.


India

Lava International Limited designs, develops, and manufactures mobile phones. The Company offers feature phones, laptops, tablets, and other mobile accessories. Lava International serves customers worldwide.

Lava International (9263793Z IN)

Lava International IPO: Forensic Analysis

Lava is one of the prominent leaders in feature phone segment, where the market is dying. Forensic takeaways pertain to ECL provisioning, absurd...

Nitin Mangal

Sahajanand Medical Technologies Pre-IPO Tearsheet

Sahajanand Medical Technologies Ltd (544309Z IN) is looking to raise US$202m in its upcoming India IPO. The deal will be run by Axis Capital, Bank...

Clarence Chu

Lava International Pre-IPO Tearsheet

Lava International (9263793Z IN) is looking to raise around US$188m in its upcoming India IPO. The deal will be run by Axis Capital, BOB Capital,...

Clarence Chu